These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32671483)

  • 1. The State of Percutaneous Intervention in Stable Coronary Artery Disease.
    Drescher C; Rao SV
    Curr Atheroscler Rep; 2020 Jul; 22(8):42. PubMed ID: 32671483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial.
    Andell P; Berntorp K; Christiansen EH; Gudmundsdottir IJ; Sandhall L; Venetsanos D; Erlinge D; Fröbert O; Koul S; Reitan C; Götberg M
    JACC Cardiovasc Interv; 2018 Oct; 11(20):2084-2094. PubMed ID: 30336812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional Flow Reserve and Instantaneous Wave-Free Ratio for Nonculprit Stenosis in Patients With Acute Myocardial Infarction.
    Choi KH; Lee JM; Kim HK; Kim J; Park J; Hwang D; Rhee TM; Park TK; Yang JH; Song YB; Shin ES; Nam CW; Doh JH; Hahn JY; Choi JH; Choi SH; Koo BK; Gwon HC
    JACC Cardiovasc Interv; 2018 Sep; 11(18):1848-1858. PubMed ID: 30236358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
    Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
    Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
    Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
    J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice patterns and trends in the use of medical therapy in patients undergoing percutaneous coronary intervention in Ontario.
    Garg P; Wijeysundera HC; Yun L; Cantor WJ; Ko DT
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25122664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Application of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention for Stable Coronary Artery Disease.
    Parikh V; Agnihotri K; Kadavath S; Patel NJ; Abbott JD
    Curr Cardiol Rep; 2016 Apr; 18(4):32. PubMed ID: 26915010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal medical therapy and percutaneous coronary intervention for stable angina: why patients should 'be taking' and 'keep taking' the tablets.
    Mohee K; Wheatcroft SB
    J Clin Pharm Ther; 2014 Aug; 39(4):331-3. PubMed ID: 24754310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor vessel fractional flow reserve and instantaneous wave-free ratio: Implications for physiology-guided PCI in patients with CTO.
    Mohdnazri SR; Karamasis GV; Al-Janabi F; Cook CM; Hampton-Till J; Zhang J; Al-Lamee R; Dungu JN; Gedela S; Tang KH; Kelly PA; Davies JE; Davies JR; Keeble TR
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E139-E148. PubMed ID: 29569332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
    Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
    Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve.
    Hakeem A; Edupuganti MM; Almomani A; Pothineni NV; Payne J; Abualsuod AM; Bhatti S; Ahmed Z; Uretsky BF
    J Am Coll Cardiol; 2016 Sep; 68(11):1181-1191. PubMed ID: 27609680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should fraction flow reserve be considered an important decision-making tool to stratify patients with stable coronary artery disease for percutaneous coronary intervention?: A meta-analysis.
    Bundhun PK; Gupta C; Huang F
    Medicine (Baltimore); 2017 Nov; 96(46):e8748. PubMed ID: 29145326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
    Bradley SM; Chan PS; Hartigan PM; Nallamothu BK; Weintraub WS; Sedlis SP; Dada M; Maron DJ; Kostuk WJ; Berman DS; Teo KK; Mancini GB; Boden WE; Spertus JA
    Am J Cardiol; 2015 Jul; 116(2):167-73. PubMed ID: 25960375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention.
    Fournier S; Ciccarelli G; Toth GG; Milkas A; Xaplanteris P; Tonino PAL; Fearon WF; Pijls NHJ; Barbato E; De Bruyne B
    JAMA Cardiol; 2019 Apr; 4(4):370-374. PubMed ID: 30840026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.
    Tandar A; Boden WE
    Curr Opin Cardiol; 2009 Nov; 24(6):591-5. PubMed ID: 19752728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Significance of Physiological Assessment of Residual Ischemia After Percutaneous Coronary Intervention.
    Ojha CP; Ibrahim A; Paul TK; Mulukutla V; Nagarajarao HS
    Curr Cardiol Rep; 2020 Feb; 22(4):17. PubMed ID: 32036467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Fractional Flow Reserve-Guided Percutaneous Cornary Intervention for Patients with Angina Pectoris.
    Shinohara H; Kodera S; Kiyosue A; Ando J; Morita H; Komuro I
    Int Heart J; 2020 Nov; 61(6):1097-1106. PubMed ID: 33191337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional flow reserve-guided PCI for stable coronary artery disease.
    De Bruyne B; Fearon WF; Pijls NH; Barbato E; Tonino P; Piroth Z; Jagic N; Mobius-Winckler S; Rioufol G; Witt N; Kala P; MacCarthy P; Engström T; Oldroyd K; Mavromatis K; Manoharan G; Verlee P; Frobert O; Curzen N; Johnson JB; Limacher A; Nüesch E; Jüni P;
    N Engl J Med; 2014 Sep; 371(13):1208-17. PubMed ID: 25176289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.